Skip to main content
. 2018 Apr 9;8(4):303–319. doi: 10.1007/s13659-018-0162-1

Table 1.

Anti-leukemia cells activities of artemisinins

Compounds Effect Event/mechanism References
Derivatives Reversed multidrug resistance Overcoming cross resistance [31, 61]
DHA Induced autophagy
Inhibited tumor growth
Expression of LC3-II, caspase-3 activation, Down-regulation of TfR expression, and cell growth arrested in the G2/M phase [62]
DHA Induced apoptosis Up-regulated the transcription factor FOXO3a [63]
ART-838 Inhibited cell growth
Reduced cell proliferation and clonogenicity
Induced apoptosis
Increased intracellular levels of ROS
Increased intracellular ROS levels [64]
ART, AS, DHA Induced apoptosis
Increased ROS generation
Induced cytotoxicity and apoptosis by activated caspase 3/7
Induced ROS generation and lysosomal disruption
[65]
DHA Inhibited tumor growth Suppressed the expression of Bcr/Abl protein, Reduced the Bcr/Abl tyrosine activity of AKT and ERK1/2, suppressed NF-κB protein expression, Promoted the cytochrome c release and activated caspase3/9 [66]
DHA Induced cell death Inhibited the Bcr/Abl fusion gene at the mRNA level
Inhibited the expression of Bcr/Abl and suppressed the activity of tyrosine kinase, suppressed the downstream signals of Bcr/Abl, reduced the tyrosine kinase activity of AKT and ERK1/2, promoted the cytochrome c release and activated caspase9/3
[67]
AS Suppressed tumor growth
Induced apoptosis
Suppressed the phosphorylation of p38, ERK, CREB, Chk-2, STAT5, and RSK proteins, Activated caspase-3, inhibited p38, ERK, STAT5, and CREB activation [68]